Mar 28, 2024 02:59 PM
Jenburkt Pharmaceuticals Ltd
SECTOR : Pharmaceuticals | BSE :524731 |
Financials( ₹ in Cr) | Jenburkt Pharmaceuticals Ltd | Sun Pharmaceuticals Industries Ltd | Cipla Ltd | Dr Reddys Laboratories Ltd | Zydus Lifesciences Ltd |
---|---|---|---|---|---|
Price | 690.00 | 1,628.90 | 1,512.90 | 6,195.25 | 1,012.90 |
% Change | -1.29 | 1.54 | 3.39 | 2.50 | 1.32 |
Mcap ₹ Cr | 304.50 | 390,827.68 | 122,143.98 | 103,342.35 | 102,526.14 |
Revenue TTM ₹ Cr | 136.75 | 43,885.68 | 15,790.60 | 24,669.70 | 17,237.40 |
Net Profit TTM ₹ Cr | 24.61 | 8,560.84 | 2,513.47 | 4,507.30 | 1,997.30 |
PE TTM | 12.62 | 41.13 | 29.93 | 19.30 | 30.34 |
1 Year Return | 0.20 | 65.63 | 70.12 | 38.11 | 110.19 |
ROCE | 26.04 | 16.79 | 14.76 | 25.99 | 16.25 |
ROE | 20.53 | 16.46 | 10.66 | 21.21 | 14.05 |
Equity Capital: 122.39 Cr FV: 10.00
Period | MF Net Purchase / (sold) | FII Net |
---|---|---|
LAST 1M | 30,755.54 | 31,723.05 |
LAST 3M | 69,913.40 | 26,515.65 |
LAST 6M | 130,081.93 | 60,306.69 |
LAST 12M | 189,259.39 | 205,003.99 |
Date | Action Type | Ratio |
---|---|---|
Jul 19, 2023 | Dividend | 144 |
Jul 21, 2022 | Dividend | 120 |
Jenburkt Pharmaceuticals Ltd, incorporated in 1985, was formed a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. It has more than 1,000 stockists and their reach extends to 400,000 pharmacies across the globe. The organisation caters to government, semi-government institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at Sihor-Gujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements. In addition, it has a Research & Development unit duly approved by the Ministry of Science & Technology, Government of India. Hence, the Company has strong manufacturing facilities to cater to domestic and international market. The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, life-changing therapeutic solutions that are accessible to all. Way back in the 20th century, a visionary in the field of healthcare and philanthropic work - Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies. Continuing the legacy of Shri Nandlal Mulji Bhuta, his sons Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta founded the Company. In 2021-22, the Company launched a new OTC division ~ Jenburkt Wellness towards better physical and mental health. The first brand launched was Zixa Strong, natural, pain relief product. Further, it launched Nervijen D3 tablets in 2022-23.
Nirmala Apartment P B No 37396, 93 Jayprakash Road Andheri(W), Mumbai, Maharashtra, 400058
Tel | : | 91-22-66943121/67603603 |
: | investor:jenburkt.com | |
Website | : | http://www.jenburkt.com |
Bigshare Services Pvt Ltd
AGM Date (Month) | : | Jul |
Face Value Equity Shares | : | 10 |
Market Lot Equity Shares | : | 1 |
BSE Code | : | 524731 |
NSE Code | : | |
Book Closure Date (Month) | : | Jul |
BSE Group | : | X |
ISIN | : | INE354A01013 |
You can buy Jenburkt Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Jenburkt Pharmaceuticals Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Mar 28, 2024 02:59 PM the closing price of Jenburkt Pharmaceuticals Ltd was ₹ 690.00.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Mar 28, 2024 02:59 PM, the market cap of Jenburkt Pharmaceuticals Ltd stood at ₹ 304.50.
The latest PE ratio of Jenburkt Pharmaceuticals Ltd as of Mar 28, 2024 02:59 PM is 12.62
The latest PB ratio of Jenburkt Pharmaceuticals Ltd as of Mar 28, 2024 02:59 PM is 0.42
The 52-week high of Jenburkt Pharmaceuticals Ltd share price is ₹ 925.00 while the 52-week low is ₹ 586.90